Hirokazu Sugiyama1, Makoto Yamaguchi1, Takayuki Katsuno1, Shiho Iwagaitsu1, Hironobu Nobata1, Hiroshi Kinashi1, Shogo Banno1, Masahiko Ando2, Yoko Kubo3, Takuji Ishimoto4, Yasuhiko Ito5. 1. Department of Nephrology and Rheumatology, Aichi Medical University, 1-1 Karimata, Yazako, Nagakute, Aichi, 480-1195, Japan. 2. Data Coordinating Center, Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan. 3. Department of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan. 4. Department of Nephrology and Renal Replacement Therapy, Nagoya University Graduate School of Medicine, Nagoya, Japan. 5. Department of Nephrology and Rheumatology, Aichi Medical University, 1-1 Karimata, Yazako, Nagakute, Aichi, 480-1195, Japan. yasuito@aichi-med-u.ac.jp.
Abstract
BACKGROUND: Although previous studies have evaluated risk factors for the incidence of severe infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV), the relationship between body mass index (BMI) and severe infection in AAV has not been elucidated. We hypothesized that older adults with AAV and a low BMI would be at a higher risk of infection. We therefore investigated the association between underweight status at AAV diagnosis and subsequent occurrence of severe infection in older adults with AAV. METHODS: This single-center retrospective cohort study included 93 consecutive older adults with microscopic polyangiitis (MPA) treated at the Aichi Medical University Hospital in Japan between 2004 and 2018. The relationships between BMI at diagnosis and subsequent first severe infection were assessed using multivariate Cox proportional hazards models. The cumulative probability of the development of the first severe infection was calculated using the Kaplan-Meier method and the log-rank test. The level of statistical significance was set at P < 0.05. RESULTS: During the median follow-up period of 19 (6-53) months, 29 (31.2%) patients developed at least one severe infection. Older age (adjusted hazard ratio [HR] = 2.02, 95% confidence interval [CI]: 1.14-3.52, per 10 years; P = 0.016), low BMI (< 18.5 kg/m2 compared with normal BMI [18.5-23.0 kg/m2], adjusted HR = 2.63, 95% CI: 1.11-6.19; P = 0.027), and use of methylprednisolone pulse therapy (adjusted HR = 2.48, 95% CI: 1.07-5.76; P = 0.034) were found to be significant predictors of severe infection. CONCLUSIONS: Low BMI was associated with a higher risk of severe infection in older adults with MPA, suggesting that careful management may be required to prevent this complication in this vulnerable group. Further studies are needed to elucidate the optimal treatment strategy for these patients.
BACKGROUND: Although previous studies have evaluated risk factors for the incidence of severe infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV), the relationship between body mass index (BMI) and severe infection in AAV has not been elucidated. We hypothesized that older adults with AAV and a low BMI would be at a higher risk of infection. We therefore investigated the association between underweight status at AAV diagnosis and subsequent occurrence of severe infection in older adults with AAV. METHODS: This single-center retrospective cohort study included 93 consecutive older adults with microscopic polyangiitis (MPA) treated at the Aichi Medical University Hospital in Japan between 2004 and 2018. The relationships between BMI at diagnosis and subsequent first severe infection were assessed using multivariate Cox proportional hazards models. The cumulative probability of the development of the first severe infection was calculated using the Kaplan-Meier method and the log-rank test. The level of statistical significance was set at P < 0.05. RESULTS: During the median follow-up period of 19 (6-53) months, 29 (31.2%) patients developed at least one severe infection. Older age (adjusted hazard ratio [HR] = 2.02, 95% confidence interval [CI]: 1.14-3.52, per 10 years; P = 0.016), low BMI (< 18.5 kg/m2 compared with normal BMI [18.5-23.0 kg/m2], adjusted HR = 2.63, 95% CI: 1.11-6.19; P = 0.027), and use of methylprednisolone pulse therapy (adjusted HR = 2.48, 95% CI: 1.07-5.76; P = 0.034) were found to be significant predictors of severe infection. CONCLUSIONS: Low BMI was associated with a higher risk of severe infection in older adults with MPA, suggesting that careful management may be required to prevent this complication in this vulnerable group. Further studies are needed to elucidate the optimal treatment strategy for these patients.
Entities:
Keywords:
Antibodies, Antineutrophil cytoplasmic antibody-associated Vasculitis; Body mass index; Infection
Authors: Elise S Braun; Forrest W Crawford; Mayur M Desai; James Meek; Pam Daily Kirley; Lisa Miller; Evan J Anderson; Oluwakemi Oni; Patricia Ryan; Ruth Lynfield; Marisa Bargsten; Nancy M Bennett; Krista L Lung; Ann Thomas; Elizabeth Mermel; Mary Lou Lindegren; William Schaffner; Andrea Price; Sandra S Chaves Journal: Infection Date: 2015-07-07 Impact factor: 3.553
Authors: Richard Watts; Suzanne Lane; Thomas Hanslik; Thomas Hauser; Bernhard Hellmich; Wenche Koldingsnes; Alfred Mahr; Mårten Segelmark; Jan W Cohen-Tervaert; David Scott Journal: Ann Rheum Dis Date: 2006-08-10 Impact factor: 19.103
Authors: Joanna Robson; Helen Doll; Ravi Suppiah; Oliver Flossmann; Lorraine Harper; Peter Höglund; David Jayne; Alfred Mahr; Kerstin Westman; Raashid Luqmani Journal: Ann Rheum Dis Date: 2013-11-15 Impact factor: 19.103
Authors: Zachary S Wallace; Na Lu; Eli Miloslavsky; Sebastian Unizony; John H Stone; Hyon K Choi Journal: Arthritis Care Res (Hoboken) Date: 2017-04-28 Impact factor: 4.794
Authors: Heidi J Urwin; Elizabeth A Miles; Paul S Noakes; Lefkothea-Stella Kremmyda; Maria Vlachava; Norma D Diaper; Keith M Godfrey; Philip C Calder; Jelena Vulevic; Parveen Yaqoob Journal: Br J Nutr Date: 2013-10-16 Impact factor: 3.718
Authors: R Kraft; D N Herndon; F N Williams; A M Al-Mousawi; C C Finnerty; M G Jeschke Journal: Int J Obes (Lond) Date: 2011-12-06 Impact factor: 5.095
Authors: Balazs Odler; Martin Windpessl; Marcell Krall; Maria Steiner; Regina Riedl; Carina Hebesberger; Martin Ursli; Emanuel Zitt; Karl Lhotta; Marlies Antlanger; Daniel Cejka; Philipp Gauckler; Martin Wiesholzer; Marcus Saemann; Alexander R Rosenkranz; Kathrin Eller; Andreas Kronbichler Journal: Front Immunol Date: 2021-10-29 Impact factor: 7.561